Will This Earnings Surprise Lead One Hard-Hit Industry's Turnaround?

Few industries in the medical device sector have been as hard-hit in recent years as the cardiac rhythm management, or CRM, business. One look around the industry tells it all. Medtronic's (NYSE: MDT  ) cardiac rhythm disease management business lost 2% of its sales year over year in its most recent fiscal year, led by its lagging defibrillator business. Boston Scientific (NYSE: BSX  ) followed closely in its larger rival's footsteps, as its own implantable cardioverter defibrillator products, or ICDs, saw sales fall nearly 4% in the most recent quarter.

Yet no company's as at risk to the CRM market's downturn as St. Jude Medical (NYSE: STJ  ) . St. Jude's even more reliant on defibrillators for its revenue than either Boston Scientific or Medtronic, as the company pulls in more than 30% of its total sales from the products. The business' downturn has taken a toll on St. Jude's finances even as this surging stock has soared in 2013.

Finally, however, hope is rising for the future. St. Jude released its third-quarter earnings Wednesday, and the results from its defibrillator business at long last showed growth. Can this result turn around St. Jude's fortunes? In the video below, Motley Fool contributor Dan Carroll tells you what you need to know about St. Jude's most important segment and whether the CRM industry can continue these gains as Medtronic and Boston Scientific report earnings in the coming weeks.

How to make the most of your financial future
St. Jude's stock has surged this year despite the company's struggles, but many investors have missed out on the best of the market's gains. Millions of Americans have waited on the sidelines since the market meltdown in 2008 and 2009, too scared to invest and put their money at further risk. Yet those who've stayed out of the market have missed out on huge gains and put their financial futures in jeopardy. In our brand-new special report, "Your Essential Guide to Start Investing Today," The Motley Fool's personal finance experts show you why investing is so important and what you need to do to get started. Click here to get your copy today -- it's absolutely free.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2688837, ~/Articles/ArticleHandler.aspx, 9/26/2016 12:01:52 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,123.18 -138.27 -0.76%
S&P 500 2,149.75 -14.94 -0.69%
NASD 5,267.69 -38.06 -0.72%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/26/2016 11:46 AM
BSX $23.73 Up +0.02 +0.08%
Boston Scientific CAPS Rating: ***
MDT $86.78 Down -0.93 -1.06%
Medtronic CAPS Rating: *****
STJ $79.09 Down -0.55 -0.69%
St. Jude Medical CAPS Rating: **